Pan-cancer and experimental analyses reveal the immunotherapeutic significance of CST2 and its association with stomach adenocarcinoma proliferation and metastasis
PurposeCystatin 2 (CST2) is a cysteine protease inhibitor, and recent research suggests its potential involvement in cancer development. However, its role in the occurrence, progression, and prognosis of pan-cancer has not been systematically investigated.Materials and methodsThis study comprehensiv...
Saved in:
Main Authors: | Dan Huang, Jing Li, Zhijun He, Wenjing Liang, Likun Zhong, Jun Huang, Yinteng Wu, Shijian Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1466806/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrating multiomics analysis and machine learning to refine the molecular subtyping and prognostic analysis of stomach adenocarcinoma
by: Miaodong Wang, et al.
Published: (2025-01-01) -
Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
by: Ziyi Zhou, et al.
Published: (2025-02-01) -
ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
by: Jiaxing Zhang, et al.
Published: (2025-02-01) -
Autoimmune gastritis pathogenesis and risk factors of stomach malignant neoplasia
by: Ye. A. Losik, et al.
Published: (2015-09-01) -
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01)